Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Newsroom
In the News

July 29, 2014
Bioniche Announces Submission of Orphan Drug Designation Application for MCNA in the United States

July 18, 2014
Bioniche Announces Intention to File for Marketing Approval of MCNA in the United States


Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Media Contacts

Please note that all media inquiries for Bioniche Life Sciences Inc. should be directed to:

Donald Olds
Chief Operating Officer

Tel: (613) 966-8058 ext. 1254 or (800) 265-5464 ext. 1254
Fax: (613) 966-4177

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy